ALIMP Implanet S.A.

0.1515USD0.1378 EUR · EPA+3.61%Mkt Cap: 21.78M USDP/E: —

Implanet S.A., together with its subsidiaries, manufactures and sells implants and medical instruments for orthopedic surgery in France, the United States, Europe, the Middle East, Africa, and internationally. The compan…

Key Statistics

Company
Market Cap21.78M USD
Enterprise Value26.67M USD
Revenue (TTM)15.17M USD
Gross Profit7.58M USD
Net Income (TTM)-4.82M USD
Revenue/Share0.11 USD
Last Price0.1515 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees49
CountryFR
SectorHealthcare
IndustryMedical Devices
ISINFR0013470168
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA-6.41
EV/Revenue1.76
P/S1.44
P/B-11.48
EPS (TTM)-0.02 USD
EPS (Forward)—
52W Range
0.14076% of range0.3144
52W High0.3144 USD
52W Low0.1407 USD
Profitability
Gross Margin55.27%
Oper. Margin-28.58%
EBITDA Margin-27.42%
Profit Margin-35.13%
ROE-1084.65%
ROA-23.75%
ROIC-118.35%
ROCE-317.54%
Growth
Revenue Growth22.80%
Earnings Growth—
Cash Flow & Leverage
Operating CF-647.43K USD
CapEx (TTM)1.71M USD
FCF Margin-7.65%
FCF Yield-5.33%
Net Debt4.89M USD
Net Debt/EBITDA-1.17
Net Debt/FCF—
Balance Sheet
Debt/Equity14.66
Current Ratio0.68
Quick Ratio0.28
Book Value/Sh-0.01 USD
Cash/Share0.0077 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Splits
Last Split1:40
Split DateFeb 3, 2020
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.143.82M
Float49.79M
Insiders66.13%
Institutions0.00%
Technical
SMA 500.1706 (-11.2%)
SMA 2000.2022 (-25.1%)
Beta0.65
S&P 52W Chg8.68%
Avg Vol (30d)70.19K
Avg Vol (10d)58.10K
Technical Indicators
RSI (14)43.4
MACD-0.0050
MACD Signal-0.0054
MACD Hist.+0.0004
BB Upper0.1707 USD
BB Middle0.1562 USD
BB Lower0.1417 USD
BB Width18.56%
ATR (14)0.0090 USD
Vol Ratio (20d)0.78x

About Implanet (EPA: ALIMP)

›

Implanet (EPA: ALIMP) is listed on Euronext Paris, where its shares trade in EUR. It belongs to the Medical Devices industry, part of the Healthcare sector, and reports about 49 employees.

The shares were at 0.1378 EUR on 20 November 2026, down 35.3% over 52 weeks. Its 52-week range is 0.1280 EUR to 0.2860 EUR: the price is 51.8% below the high and 7.7% above the low.

Its market capitalisation is 19.82M EUR.

Implanet reports an operating margin of -28.6% and revenue up 22.8% year over year.

Its debt exceeds its cash by 4.45M EUR, a debt-to-equity ratio of 14.66. Its Piotroski F-score is 5 out of 9, an average reading of its financial health.